Location: Oslo, Norway
CIK: 0001475373 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 12, 2026
Total Value: $461M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 33,584 | $16.84M | 3.7% | $501.36 | — | COM | 883556102 |
| REGN | REGENERON PHARMACEUTICALS | 15,780 | $9.839M | 2.1% | $623.54 | — | COM | 75886F107 |
| ASND | ASCENDIS PHARMA A/S | 21,305 | $5.682M | 1.2% | $266.72 | — | ORD SHS | K08588103 |
| BSX | BOSTON SCIENTIFIC CORP | 121,128 | $5.17M | 1.1% | $42.68 | — | COM | 101137107 |
| TVTX | TRAVERE THERAPEUTICS INC | 80,000 | $4.545M | 1.0% | $56.81 | — | COM | 89422G107 |
| CYTK | CYTOKINETICS INC | 45,000 | $3.834M | 0.8% | $85.19 | — | COM NEW | 23282W605 |
| NTLA | INTELLIA THERAPEUTICS INC | 185,177 | $3.133M | 0.7% | $16.92 | — | COM | 45826J105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IQV | IQVIA HLDGS INC | 77,944 (+93.7%) | $15.06M (+119.5%) | 3.3% | $201.96 | — | COM | 46266C105 |
| CVS | CVS HEALTH CORP | 155,337 (+14.8%) | $16.07M (+65.3%) | 3.5% | $70.44 | — | COM | 126650100 |
| QGEN | QIAGEN NV | 287,640 (+77.1%) | $11.25M (+73.0%) | 2.4% | $45.43 | — | ORD SHARES | N72482156 |
| ABT | ABBOTT LABS | 147,444 (+68.4%) | $13.38M (+48.9%) | 2.9% | $105.39 | — | COM | 002824100 |
| ELV | ELEVANCE HEALTH INC FORMERLY | 44,499 (+1.2%) | $17.21M (+33.7%) | 3.7% | $351.64 | — | COM | 036752103 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 207,863 (+64.4%) | $13.31M (+47.9%) | 2.9% | $71.80 | — | COMMON STOCK | 36266G107 |
| AVTR | AVANTOR INC | 906,088 (+30.3%) | $8.97M (+64.5%) | 1.9% | $12.38 | — | COM | 05352A100 |
| DXCM | DEXCOM INC | 102,122 (+82.0%) | $6.878M (+95.1%) | 1.5% | $73.56 | — | COM | 252131107 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 294,918 (+22.9%) | $16.88M (+24.5%) | 3.7% | $67.57 | — | COM | 09061G101 |
| MDT | MEDTRONIC PLC | 352,437 (+25.6%) | $27.57M (+13.4%) | 6.0% | $83.12 | — | SHS | G5960L103 |
| BIO | BIO RAD LABS INC | 33,350 (+40.4%) | $9.792M (+47.9%) | 2.1% | $294.17 | — | CL A | 090572207 |
| PTCT | PTC THERAPEUTICS INC | 100,000 (+33.3%) | $8.157M (+59.6%) | 1.8% | $58.80 | — | COM | 69366J200 |
| IONS | IONIS PHARMACEUTICALS INC | 189,468 (+11.8%) | $15.02M (+18.1%) | 3.3% | $49.60 | — | COM | 462222100 |
| LH | LABCORP HOLDINGS INC | 26,019 (+36.8%) | $7.285M (+43.6%) | 1.6% | $257.11 | — | COM SHS | 504922105 |
| KURA | KURA ONCOLOGY INC | 433,012 (+5.1%) | $4.75M (+41.9%) | 1.0% | $7.44 | — | COM | 50127T109 |
| BDX | BECTON DICKINSON & CO | 93,168 (+12.8%) | $14.1M (+8.5%) | 3.1% | $204.75 | — | COM | 075887109 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 968,466 (+7.6%) | $4.029M (+27.5%) | 0.9% | $2.78 | — | COM | 462260100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 114,628 (+21.7%) | $4.289M (+25.4%) | 0.9% | $43.25 | — | COM | 22663K107 |
| ARDX | ARDELYX INC | 686,844 (+33.1%) | $3.503M (+13.3%) | 0.8% | $6.58 | — | COM | 039697107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 36,435 | $9.859M | 2.1% | $308.69 | — | — | 91324P102 |
| GILD | GILEAD SCIENCES INC | 53,247 | $7.421M | 1.6% | $75.45 | — | — | 375558103 |
| LNTH | LANTHEUS HLDGS INC | 93,344 | $7.08M | 1.5% | $74.91 | — | — | 516544103 |
| ASND | ASCENDIS PHARMA A/S | 21,305 | $4.873M | 1.1% | $182.86 | — | — | 04351P101 |
| HUM | HUMANA INC | 19,202 | $3.329M | 0.7% | $223.53 | — | — | 444859102 |
| BBIO | BRIDGEBIO PHARMA INC | 44,263 | $3.287M | 0.7% | $74.48 | — | — | 10806X102 |
| DNLI | DENALI THERAPEUTICS INC | 162,710 | $3.124M | 0.7% | $19.63 | — | — | 24823R105 |
| COGT | COGENT BIOSCIENCES INC | 80,000 | $3.079M | 0.7% | $37.37 | — | — | 19240Q201 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 30,000 | $1.881M | 0.4% | $65.73 | — | — | 04280A100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 726,115 (-12.3%) | $41.84M (-16.7%) | 9.1% | $49.36 | — | COM | 110122108 |
| AMGN | AMGEN INC | 26,281 (-44.3%) | $9.517M (-42.6%) | 2.1% | $285.08 | — | COM | 031162100 |
| PFE | PFIZER INC | 1,004,215 (-8.0%) | $24.18M (-21.1%) | 5.2% | $25.58 | — | COM | 717081103 |
| BIIB | BIOGEN INC | 54,163 (-39.9%) | $11.7M (-29.2%) | 2.5% | $165.19 | — | COM | 09062X103 |
| MRK | MERCK & CO INC | 217,008 (-16.6%) | $27.89M (-11.0%) | 6.0% | $80.39 | — | COM | 58933Y105 |
| CAH | CARDINAL HEALTH INC | 40,689 (-25.9%) | $9.666M (-16.7%) | 2.1% | $64.47 | — | COM | 14149Y108 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 142,307 (-8.7%) | $12.25M (-13.1%) | 2.7% | $104.78 | — | COM | 98956P102 |
| OGN | ORGANON & CO | 270,781 (-28.0%) | $3.666M (+62.8%) | 0.8% | $9.46 | — | COMMON STOCK | 68622V106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 241,739 (-15.5%) | $5.284M (-20.9%) | 1.1% | $14.63 | — | COM | 87164F105 |
| INCY | INCYTE CORP | 170,753 (-14.8%) | $19.36M (+2.6%) | 4.2% | $71.18 | — | COM | 45337C102 |
| BRKR | BRUKER CORP | 152,352 (-40.0%) | $9.169M (-0.1%) | 2.0% | $51.49 | — | COM | 116794108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CNC | CENTENE CORP DEL | 162,405 | $10.42M | 2.3% | $53.34 | — | COM | 15135B101 |
| TNDM | TANDEM DIABETES CARE INC | 267,091 | $4.03M | 0.9% | $24.77 | — | COM NEW | 875372203 |
| EW | EDWARDS LIFESCIENCES CORP | 60,402 | $5.464M | 1.2% | $78.07 | — | COM | 28176E108 |